Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 285

1.

The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer.

Avila DM, Zoppi S, McPhaul MJ.

J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):135-42. Review.

PMID:
11384871
[PubMed - indexed for MEDLINE]
2.

Molecular defects of the androgen receptor.

McPhaul MJ.

J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):315-22. Review.

PMID:
10419008
[PubMed - indexed for MEDLINE]
3.

Molecular basis of androgen insensitivity.

Brinkmann AO.

Mol Cell Endocrinol. 2001 Jun 20;179(1-2):105-9. Review.

PMID:
11420135
[PubMed - indexed for MEDLINE]
4.

Androgen receptor mutations and androgen insensitivity.

McPhaul MJ.

Mol Cell Endocrinol. 2002 Dec 30;198(1-2):61-7. Review.

PMID:
12573815
[PubMed - indexed for MEDLINE]
5.

Molecular defects of the androgen receptor.

McPhaul MJ.

Recent Prog Horm Res. 2002;57:181-94. Review.

PMID:
12017542
[PubMed - indexed for MEDLINE]
6.

Collocation of androgen receptor gene mutations in prostate cancer.

Buchanan G, Greenberg NM, Scher HI, Harris JM, Marshall VR, Tilley WD.

Clin Cancer Res. 2001 May;7(5):1273-81.

PMID:
11350894
[PubMed - indexed for MEDLINE]
Free Article
7.

Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.

Yong EL, Tut TG, Ghadessy FJ, Prins G, Ratnam SS.

Mol Cell Endocrinol. 1998 Feb;137(1):41-50. Review.

PMID:
9607727
[PubMed - indexed for MEDLINE]
8.

Androgen-receptor gene structure and function in prostate cancer.

Hakimi JM, Rondinelli RH, Schoenberg MP, Barrack ER.

World J Urol. 1996;14(5):329-37. Review.

PMID:
8912473
[PubMed - indexed for MEDLINE]
9.

Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence.

Taplin ME, Balk SP.

J Cell Biochem. 2004 Feb 15;91(3):483-90. Review.

PMID:
14755679
[PubMed - indexed for MEDLINE]
10.

Mutations of androgen receptor gene in androgen insensitivity syndromes.

Sultan C, Lumbroso S, Poujol N, Belon C, Boudon C, Lobaccaro JM.

J Steroid Biochem Mol Biol. 1993 Nov;46(5):519-30. Review.

PMID:
8240973
[PubMed - indexed for MEDLINE]
11.

[Mutations of the androgen receptor gene a possible role in prostate cancer].

Mowszowicz I, Mestayer C.

Bull Cancer. 1997 Feb;84(2):183-8. Review. French.

PMID:
9180843
[PubMed - indexed for MEDLINE]
12.

Defects of androgen receptor function: from sex reversal to motor neurone disease.

MacLean HE, Warne GL, Zajac JD.

Mol Cell Endocrinol. 1995 Aug 11;112(2):133-41. Review.

PMID:
7489816
[PubMed - indexed for MEDLINE]
13.

Broadened ligand responsiveness of androgen receptor mutants obtained by random amino acid substitution of H874 and mutation hot spot T877 in prostate cancer.

Steketee K, Timmerman L, Ziel-van der Made AC, Doesburg P, Brinkmann AO, Trapman J.

Int J Cancer. 2002 Jul 20;100(3):309-17.

PMID:
12115546
[PubMed - indexed for MEDLINE]
14.

Androgen receptor signaling in androgen-refractory prostate cancer.

Grossmann ME, Huang H, Tindall DJ.

J Natl Cancer Inst. 2001 Nov 21;93(22):1687-97. Review.

PMID:
11717329
[PubMed - indexed for MEDLINE]
Free Article
15.

Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.

Tilley WD, Buchanan G, Hickey TE, Bentel JM.

Clin Cancer Res. 1996 Feb;2(2):277-85.

PMID:
9816170
[PubMed - indexed for MEDLINE]
Free Article
16.

Androgen receptor involvement in the progression of prostate cancer.

Suzuki H, Ueda T, Ichikawa T, Ito H.

Endocr Relat Cancer. 2003 Jun;10(2):209-16. Review.

PMID:
12790784
[PubMed - indexed for MEDLINE]
Free Article
17.

[Clinical consequences of androgen receptor malfunction].

Klocker H, Eder IE, Culig Z, Bartsch G.

Verh Dtsch Ges Pathol. 2004;88:122-9. Review. German.

PMID:
16892542
[PubMed - indexed for MEDLINE]
18.

Mechanisms and clinical relevance of androgens and androgen receptor actions.

Kang HY, Tsai MY, Chang C, Huang KE.

Chang Gung Med J. 2003 Jun;26(6):388-402. Review.

PMID:
12956285
[PubMed - indexed for MEDLINE]
Free Article
19.

Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer.

Ray MR, Wafa LA, Cheng H, Snoek R, Fazli L, Gleave M, Rennie PS.

Int J Cancer. 2006 Mar 1;118(5):1108-19.

PMID:
16161052
[PubMed - indexed for MEDLINE]
20.

Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.

Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.

Cancer Res. 2004 Oct 1;64(19):7156-68.

PMID:
15466214
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk